Neuroendocrine differentiation in cervical carcinoma

被引:25
|
作者
Savargaonkar, PR
Hale, RJ
Mutton, A
Manning, V
Buckley, CH
机构
[1] STEPPING HILL HOSP,DEPT PATHOL,STOCKPORT,CHESHIRE,ENGLAND
[2] ST MARYS HOSP,DEPT REPROD PATHOL,MANCHESTER M13 0JH,LANCS,ENGLAND
[3] N MANCHESTER GRP HOSP,MANCHESTER,LANCS,ENGLAND
关键词
neuroendocrine tumours; chromogranin A; cervical carcinoma;
D O I
10.1136/jcp.49.2.139
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Aims-To examine neuroendocrine differentiation, as shown by chromogranin A (CGA) expression, in cervical carcinomas. Methods-Sixty seven cervical carcinomas were studied and were classified as adenocarcinomas, adenosquamous carcinomas or squamous cell carcinomas based on the assessment of haematoxylin and eosin staining and stains for mucin. Where features of glandular differentiation were identified, sections were also stained for evidence of intestinal type mucin. CGA immunostaining was done and the results were graded on a three point scale: 0, + (1-5% of cells positive) and + + (>5% of cells positive). These findings were then analysed with respect to lymph node status, tumour differentiation and clinical outcome. Results-There were 32 adenocarcinomas, 18 adenosquamous carcinomas and 17 squamous cell carcinomas. Positive staining was seen in 14 (20.9%) cases, of which four were strongly positive. All but one case were either adenocarcinomas or adenosquamous carcinomas. There was a trend for CGA positivity to be related to intestinal differentiation but this failed to reach statistical significance. No correlation could be demonstrated between CGA staining and lymph node status, tumour differentiation and clinical outcome. Conclusions Neuroendocrine differentiation is common in cervical carcinomas where there is evidence of glandular differentiation. Whilst the numbers in this study are relatively small, the presence of neuroendocrine cells in otherwise typical carcinomas does not seem to have any association with clinical behaviour.
引用
收藏
页码:139 / 141
页数:3
相关论文
共 50 条
  • [11] NEUROENDOCRINE DIFFERENTIATION IN PROSTATIC-CARCINOMA
    DISANTAGNESE, PA
    DEMESYJENSEN, KL
    OTOOLE, K
    LABORATORY INVESTIGATION, 1986, 54 (01) : A16 - A16
  • [12] NEUROENDOCRINE DIFFERENTIATION IN PROSTATIC-CARCINOMA
    DISANTAGNESE, PA
    JENSEN, KLD
    HUMAN PATHOLOGY, 1987, 18 (08) : 849 - 856
  • [13] NEUROENDOCRINE DIFFERENTIATION IN LUNG-CARCINOMA
    ADDIS, BJ
    THORAX, 1995, 50 (02) : 113 - 115
  • [14] Dual Carcinoma of the Breast with Neuroendocrine Differentiation
    Flessas, Ioannis
    Tsamis, Dimitrios
    Michalopoulos, Nikolaos V.
    Chrysikos, Dimosthenis
    Liakou, Paraskevi
    Linardoutsos, Dimitrios
    Zagouri, Flora
    Zografos, Georgios
    AMERICAN SURGEON, 2012, 78 (11) : E457 - E458
  • [15] Mucinous carcinoma of the breast with neuroendocrine differentiation
    Nakagawa, H
    Shikata, N
    Senzaki, H
    Uemura, Y
    Inoue, T
    Kashu, S
    Tsubura, A
    PATHOLOGY INTERNATIONAL, 2000, 50 (08) : 644 - 648
  • [16] Thymic carcinoma with neuroendocrine differentiation in a calf
    Anjiki, T
    Kadota, K
    JOURNAL OF VETERINARY MEDICAL SCIENCE, 1999, 61 (07): : 853 - 855
  • [17] Breast carcinoma with metaplastic and neuroendocrine differentiation
    Roumbas, C.
    Sassi, M.
    Tepelenis, N.
    Kapnias, D.
    Aggeli, C.
    Choreftaki, T.
    VIRCHOWS ARCHIV, 2024, 485 : S207 - S207
  • [18] Significance of neuroendocrine differentiation in prostatic carcinoma
    Hoosein, N
    Abdul, M
    Logothetis, C
    CANCER JOURNAL - FRANCE, 1996, 9 (06): : 291 - 295
  • [19] Relevance of the neuroendocrine differentiation in prostatic carcinoma
    Sauer, CG
    Trojan, L
    Grobholz, R
    PATHOLOGE, 2005, 26 (06): : 444 - +
  • [20] Neuroendocrine differentiation and prognosis in breast carcinoma
    Miremadi, A
    Pinder, SE
    Lee, AHS
    Bell, JA
    Paish, C
    Wencyk, PM
    Elston, CW
    Nicholson, RI
    Blamey, RW
    Robertson, JF
    Ellis, IO
    JOURNAL OF PATHOLOGY, 2001, 195 : 28A - 28A